Investment
Features
FeesSafety
Academy
More
Pluang+

BitMart faces insolvency claims as users report frozen withdrawals amid exchange wind-down.

Market News
10 Aug 2026
Crypto news
View Source
Bearish
pluang ai news

BitMart is under scrutiny after a co-founder of OpenGradient claimed his market-making team cannot withdraw funds locked on the exchange, raising insolvency concerns. BitMart is winding down operations but insists withdrawals remain available, though they may be delayed due to security checks. The exchange's founder denied misuse of customer funds but has yet to publish a full proof-of-reserves report, leaving questions about its liquidity and solvency. Users, especially in the US, face additional withdrawal restrictions as BitMart phases out trading services by early 2027.

More News

Insight Enterprises' price target raised to $180 after strong Q2 earnings and revenue growth.

Insight Enterprises' price target raised to $180 after strong Q2 earnings and revenue growth.

Insight Enterprises reported impressive Q2 results with earnings per share of $3.86, beating estimates by nearly 31%, and revenue of $2.40 billion, up 15% year-over-year. Gross profit increased by 18%, prompting the company to raise its full-year fin...

Analyst Insights
Bullish
20 minutes ago
Analyst raises iRhythm price target to $168 after strong Q2 earnings beat expectations.

Analyst raises iRhythm price target to $168 after strong Q2 earnings beat expectations.

iRhythm Technologies reported strong Q2 results with revenue up 20.1% to $224.2 million and earnings of $0.58 per share, beating expectations. Profitability improved with a gross margin of 72.8% and adjusted EBITDA of $43.3 million. Following this, T...

Analyst Insights
Bullish
1 hour ago
Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.

Heron Therapeutics reported a Q2 loss per share of -$0.03, missing analyst expectations of -$0.02, with revenue of $37.67 million falling short of the $42.19 million estimate. Despite 44% growth in its acute-care franchise, slower expansion of key pr...

Company Fundamentals
Bearish
1 hour ago
Teleflex reports Q2 revenue growth and $2B divestitures, plans debt cut and share buybacks

Teleflex reports Q2 revenue growth and $2B divestitures, plans debt cut and share buybacks

Teleflex reported Q2 revenue of $570.3 million, driven by its Vascular and Surgical segments, with adjusted EPS up 1.7% to $1.76. The company is selling its Acute Care, Interventional Urology, and OEM businesses for about $2.03 billion in cash to red...

Company Fundamentals
Bullish
2 hours ago
Sun Life Financial beats Q2 estimates, raises price target to C$119 on strong insurance sales and asset growth

Sun Life Financial beats Q2 estimates, raises price target to C$119 on strong insurance sales and asset growth

Sun Life Financial reported strong Q2 results with earnings of $1.46 per share and revenues of $10.10 billion, surpassing analyst expectations. Growth was driven by a 27% rise in group insurance sales, 16% increase in individual sales, and a 10% boos...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App